MBOT Stock Summary and Trading Ideas (Microbot Medical | NASDAQ:MBOT)

Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.

Microbot Medical trades on the NASDAQ stock market under the symbol MBOT.

As of November 5, 2026, MBOT stock price declined to $1.07 with 1,361,002 million shares trading.

MBOT has a beta of 1.50, meaning it tends to be more sensitive to market movements. MBOT has a correlation of 0.07 to the broad based SPY ETF.

MBOT has a market cap of $71.86 million. This is considered a Micro Cap stock.

Last quarter Microbot Medical reported $241,000 in Revenue and -$.08 earnings per share. This fell short of revenue expectation by $-141,000 and met earnings estimates .

In the last 3 years, MBOT traded as high as $4.67 and as low as $.82.

The top ETF exchange traded funds that MBOT belongs to (by Net Assets): VTI, VXF, IWC, QQQS.

MBOT has underperformed the market in the last year with a return of -49.5%, while the SPY ETF gained +9.3%. In the last 3 month period, MBOT fell short of the market, returning -42.2%, while SPY returned -4.5%. However, in the most recent 2 weeks MBOT has outperformed the stock market by returning +13.6%, while SPY returned -4.1%.

MBOT support price is $1.08 and resistance is $1.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MBOT shares will trade within this expected range on the day.